학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 5,882건 | 목록 1~20
Academic Journal
Keshavarzian T; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Furlano K; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Grillo G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Mout L; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Arlidge C; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Hasan F; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Nand A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Mikutenaite M; Biotech Research & Innovation Centre (BRIC), The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Karadoulama E; Biotech Research & Innovation Centre (BRIC), The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Goyal A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer-related Advanced Research and Education, TCG CREST, Kolkata, India.; Pezzuto EL; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heilmann J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sykora J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Minner S; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Schlomm T; Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Sauter G; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Simon R; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; He HH; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Weischenfeldt J; Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Cancer-related Advanced Research and Education, TCG CREST, Kolkata, India.; Department of Oncology, The DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Gerhäuser C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.gerhauser@dkfz-heidelberg.de.; Lupien M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. mathieu.lupien@uhn.ca.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. mathieu.lupien@uhn.ca.; Ontario Institute for Cancer Research, Toronto, ON, Canada. mathieu.lupien@uhn.ca.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Mikutenaite M; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Karadoulama E; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Favero F; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Locallo A; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Gonzalez FGR; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Kiriy D; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Keshavarzian T; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Furlano K; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Bristow RG; Manchester Cancer Research Centre and Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Christie NHS Foundation Trust, Manchester, UK.; Div Cancer Sciences, FBMH, University of Manchester, Manchester, UK.; Gerhäuser C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Lupien M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Minner S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Schlomm T; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Weischenfeldt J; The Finsen Laboratory, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. joachim.weischenfeldt@bric.ku.dk.; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. joachim.weischenfeldt@bric.ku.dk.; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany. joachim.weischenfeldt@bric.ku.dk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
IEEE/ACM Transactions on Computational Biology and Bioinformatics IEEE/ACM Trans. Comput. Biol. and Bioinf. Computational Biology and Bioinformatics, IEEE/ACM Transactions on. 18(6):2635-2648 Jan, 2021
Academic Journal
Llamazares-Prada M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; BioMed X Institute, Heidelberg, Germany.; Schwartz U; BioMed X Institute, Heidelberg, Germany.; NGS Analysis Center Biology and Pre-Clinical Medicine, University of Regensburg, Regensburg, Germany.; Pease DF; School of Biosciences, Cardiff University, Cardiff, UK.; Pohl ST; School of Biosciences, Cardiff University, Cardiff, UK.; Ackesson D; School of Biosciences, Cardiff University, Cardiff, UK.; Li R; School of Biosciences, Cardiff University, Cardiff, UK.; Behrendt A; BioMed X Institute, Heidelberg, Germany.; Tamas R; BioMed X Institute, Heidelberg, Germany.; Stammler V; BioMed X Institute, Heidelberg, Germany.; Richter M; BioMed X Institute, Heidelberg, Germany.; Muley T; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany.; Scherer M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Hey J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Espinet E; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), and Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Heußel CP; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.; Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.; Warth A; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany.; Pathological Institute, University Hospital Heidelberg, Heidelberg, Germany.; Institute of Pathology, Cytopathology and Molecular Pathology MVZ UEGP Gießen/Wetzlar/Limburg/Bad Hersfeld, Wetzlar, Germany.; Schneider MA; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany.; Winter H; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Surgery, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany.; Herth FJ; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Translational Research Unit, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany.; Department of Pneumology and Critical Care Medicine and Translational Research Unit, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany.; Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Benes V; Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Wyatt D; Biotherapeutics Discovery, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Jurkowski TP; School of Biosciences, Cardiff University, Cardiff, UK.; Stahl HF; Immunology and Respiratory Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Jurkowska RZ; BioMed X Institute, Heidelberg, Germany. jurkowskar@cardiff.ac.uk.; School of Biosciences, Cardiff University, Cardiff, UK. jurkowskar@cardiff.ac.uk.
Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Academic Journal
Lin YY; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Breuer K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Lafrenz P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Sarnataro A; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.; Wilk A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Chepeleva M; Multiomics Data Science Research Group, Department of Cancer Research, Luxembourg Institute of Health, 1445 Strassen, Luxembourg.; Mücke O; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Petermann F; NGS Core Facility, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Kensche PR; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Weiser L; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Thommen F; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Giacomelli G; Berlin Institute of Health, University Hospital Charité, 10178 Berlin, Germany.; Nordstroem K; Department of EpiGenetics, Saarland University, 66123 Saarbrücken, Germany.; Gonzalez-Avalos E; Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA 92037, United States.; Merkel A; Bioinformatics Development and Statistical Genomics, Center for Genomic Regulation (CRG), Centro Nacional de Análisis Genómico (CNAG), 08028 Barcelona, Spain.; Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Catalonia, Spain.; Kretzmer H; LIFE-Leipzig Research Center for Civilization Diseases, University Leipzig, 04103 Leipzig, Germany.; Max-Planck Institute for Molecular Genetics, 14195 Berlin, Germany.; Fischer J; Department for Computer Vision and Machine Learning, Max Planck Institute for Informatics, 66123 Saarbrücken, Germany.; Krämer S; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg,86159 Augsburg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.; Iskar M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Wolf S; NGS Core Facility, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Buchhalter I; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Catalonia, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Catalonia, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC), 28029 Madrid, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), 08036 Barcelona, Catalonia, Spain.; Lawerenz C; Berlin Institute of Health, University Hospital Charité, 10178 Berlin, Germany.; Twardziok S; Berlin Institute of Health, University Hospital Charité, 10178 Berlin, Germany.; Zapatka M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Hovestadt V; Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, United States.; Schlesner M; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg,86159 Augsburg, Germany.; Schulz MH; Institute for Computational Genomic Medicine, Goethe University,60590 Frankfurt-am-Main, Germany.; German Center for Cardiovascular Research, 60590 Frankfurt-am-Mein, Germany.; Hoffmann S; LIFE-Leipzig Research Center for Civilization Diseases, University Leipzig, 04103 Leipzig, Germany.; Computational Biology Group, Leibniz Institute on Aging-Fritz Lipmann Institute and Friedrich Schiller, University of Jena, 07745 Jena, Germany.; Gerhauser C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Walter J; Department of EpiGenetics, Saarland University, 66123 Saarbrücken, Germany.; Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke-University,39120 Magdeburg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.; Assenov Y; Department of Mathematics and Technology, RheinAhrCampus Remagen, University of Applied Sciences Koblenz, 53424 Remagen, Germany.; Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.; Institute of Artificial Intelligence, Center for Medical Data Science, Medical University of Vienna,1090 Vienna, Austria.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Toth R; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Multiomics Data Science Research Group, Department of Cancer Research, Luxembourg Institute of Health, 1445 Strassen, Luxembourg.; Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Plass, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어